(NewsVoir); With Indian pharmaceutical exports to the United States and other markets showing a marked increase over the last year, government regulatory agencies have started emphasizing the need to ensure consistent quality of drugs manufactured in India. The drugs standardization compliance and regulatory requirements need to be at par with the international regulations, including the US FDA, allowing drug manufacturers to maintain competitive advantage.
A team of researchers from CSIR-CIMAP (Council of Scientific and Industrial Research-Central Institute of Medical & Aromatic Plants) in Lucknow have successfully completed the genome sequencing of Tulsi (Basil) plant and very soon are expected to unravel the therapeutic secrets of its medical properties. This is the first report of complete genome sequence of a traditional and most respected medicinal plant of India, using a composite next generation sequencing technologies.
Drugs Controller General India (DCGI) has issued a notice in observance of the compliance for patient safety which seems more appealing and beneficial. DCGI notified to drug importers that they will inform or report to Indian authorities about time to time regulatory actions taken on their drugs in different countries where drugs are sold or distributed.
National Pharmaceutical Pricing Authority (NPPA) given a final opportunity to companies to register with Integrated Pharmaceutical Database Management System (IPDMS). 19 companies out of Top 100, which have not yet registered with IPDMS as on 01.06.2015.
Around 11 per cent of the people in Delhi are suffering from asthma the government said while attributing its causes to smoking and air pollution.
The Indian Council of Medical Research (ICMR) will soon start research on stillbirth to identify and understand the local causes and risk factors from the medical and sociological perspective. ICMR's initiative on stillbirth is significant as nearly 3 million third-trimester stillbirths occurring worldwide each year and 98 per cent of these occur in low-income and middle-income countries. More than 1 million stillbirths occur in the intrapartum period, which can largely be prevented. The cause of stillbirth remains unidentified in India.
The Government proposes to soon open 1000 more stores under the ‘Jan Aushadhi Scheme’ to make available quality generic medicines at affordable prices through these special outlets.
The Minister of Health & Family Welfare Shri Jagat Prakash Nadda successfully steered the proceedings of the 68th Session of the World Health Assembly in his capacity as its President. It was after a gap of 19 years that India assumed the Presidency of the World Health Assembly, the highest decision making body of the World Health Organisation. The 68th WHA took place in Geneva from 18-26 May 2015.
An autonomous body under the AYUSH department of Union Health Ministry is planning to tieup with top homeopathy research organisations with an aim of boosting the healthcare industry. The Central Council for Research in Homeopathy (CCRH), the autonomous body under AYUSH, has called for further research to promote this system of medicine, said Dr R K Manchanda, Director General of CCRH.
(Business Wire India); Today, at the 2015 Commonwealth Health Ministers’ Meeting in Geneva, The Queen Elizabeth Diamond Jubilee Trust and partner Standard Chartered have unveiled an exclusive preview of Time to See, a landmark photography exhibition which captures the human impact of avoidable blindness in the Commonwealth, and the solutions readily available.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
